
- Pharmaceutical Executive-06-03-2009
- Volume 0
- Issue 0
Elaine Eisen, CORBETT WORLDWIDE HEALTHCARE COMMUNICATIONS
Virtually all pharmaceutical manufacturers have robust policies to place needed medicines in the hands of those who cannot afford to pay for them.
Elaine Eisen
PRESIDENT | CORBETT WORLDWIDE HEALTHCARE COMMUNICATIONS
Ironically, pharma has many patient assistance programs already firmly in place (established well before the current economic downturn). There is probably no other industry in America that has as many established initiatives to assure continuity of care for the customer.
Virtually all pharmaceutical manufacturers have robust policies to place needed medicines in the hands of those who cannot afford to pay for them. Although this is certainly not an exhaustive list, what follows is merely a portion of the programs that pharma has sponsored to safeguard the health of patients: the AstraZeneca Prescription Savings Program, the Merck Patient Assistance Program, the Alcon U.S. Patient Assistance Program, the Pfizer Friends Program, the Bristol-Myers Squibb Patient Assistance Foundation, the Procter & Gamble Pharmaceuticals Patient Assistance Program, and the Sanofi-Aventis Patient Assistance Program. Perhaps pharma needs to "toot its own horn" a little more loudly and recognize that those of us who work in the pharmaceutical industry are dedicated to extending and enhancing human life.
Elaine Eisen
Articles in this issue
over 16 years ago
I've Seen The Revolution and It's Not Workingover 16 years ago
Frank X. Powers, DUDNYKover 16 years ago
Didi Discar, MEDACCESSover 16 years ago
Rich Campbell, REGAN CAMPBELL WARD?MCCANNover 16 years ago
Joe Daley, GSW WORLDWIDEover 16 years ago
Kerry Hilton, HC&B HEALTHCARE COMMUNICATIONSover 16 years ago
Jon Hudson, MEDTHINK COMMUNICATIONSover 16 years ago
Jeff Burkel, MICROMASS COMMUNICATIONSover 16 years ago
Wendy Blackburn, INTOUCH SOLUTIONSover 16 years ago
Ross Fetterolf, IGNITE HEALTHNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.





